Estee Lauder Companies Inc (EL) Stock News

Rosen Law Firm has issued multiple securities class action deadline alerts for investors. The primary case involves Sportradar Group AG (SRAD), where investors who purchased shares between November 7, 2024 and April 21, 2026 may be entitled to compensation. The lawsuit alleges that Sportradar made false statements about compliance and worked with black-market gambling operators while claiming strict regulatory adherence. The lead plaintiff deadline is July 17, 2026. Similar deadline alerts were also issued for FS KKR Capital Corp. (FSK) and Regencell Bioscience Holdings Limited (RGC).

Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited (RGC) and AeroVironment, Inc. (AVAV) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and financial exposure during their respective class periods.

Rosen Law Firm has filed a class action lawsuit against BitGo Holdings, Inc. on behalf of investors who purchased securities during the company's January 2026 IPO and through May 13, 2026. The lawsuit alleges that BitGo's offering documents contained materially false and misleading statements, specifically understating risks related to declining digital asset prices and their impact on the company's business and financial performance. Investors must move the court by August 7, 2026 to serve as lead plaintiff.

Rosen Law Firm has filed a securities class action lawsuit against SES AI Corporation, alleging the company made materially false and misleading statements about business prospects, overstated deal results, created artificial revenue through circular transactions, and failed to disclose material logistics constraints affecting 2025-2026 revenues. Investors with losses exceeding $100K are encouraged to join the class action before the June 26, 2026 deadline.

Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and an executive's violation of a non-disclosure agreement. Investors with losses exceeding $100,000 are encouraged to join the class action before the June 29, 2026 deadline.

BioAge Labs announced the first participant has been dosed in QUELL-CV, a Phase 2 proof-of-concept trial evaluating BGE-102, an oral NLRP3 inhibitor for cardiovascular risk reduction. The randomized, double-blind, placebo-controlled trial will enroll approximately 160 participants with obesity and elevated inflammation across three dose levels. Phase 1 results showed BGE-102 achieved median hsCRP reductions of 86% and was well tolerated. Topline data are anticipated in the second half of 2026, with an additional Phase 1b/2a trial in diabetic macular edema planned for mid-2026.

Rosen Law Firm has filed a class action lawsuit against Erasca, Inc. on behalf of investors who purchased common stock between January 14, 2025 and April 26, 2026. The lawsuit alleges that Erasca and its executives made false and misleading statements about its lead oncology drug candidate ERAS-0015, including improper comparisons to a competing drug and undisclosed patent disputes. Investors who wish to serve as lead plaintiff must file by August 10, 2026.

Rosen Law Firm is soliciting investors who purchased Sportradar Group AG shares between November 7, 2024 and April 21, 2026 to join a securities class action lawsuit. The lawsuit alleges that Sportradar made false statements about compliance and ethics while secretly working with black-market gambling operators and maintaining inadequate Know-Your-Customer processes. The lead plaintiff deadline is July 17, 2026.

FREELANDER, a British premium intelligent all-terrain SUV brand, has officially announced the dimensions of its first strategic model, the FREELANDER 8 (5,118mm length, 2,050mm width, 1,926mm height). The vehicle was showcased at the Abu Dhabi Investment Forum on June 11, 2026, ahead of its Middle East launch. The FREELANDER 8 features advanced technologies including a Qualcomm Snapdragon 8295P-powered intelligent cockpit, an Intelligent All-Terrain System (i-ATS), and Super Intelligent Parking (SIP) capabilities optimized for high-temperature environments.

Rosen Law Firm is investigating potential securities claims against Elauwit Connection, Inc. (NASDAQ: ELWT) following the company's announcement on February 27, 2026, that it must restate previously issued interim financial statements due to errors in network construction project revenue recognition during the first nine months of 2025. The disclosure resulted in a 6.8% stock price decline. The firm is preparing a class action lawsuit to recover investor losses.

Elicio Therapeutics announced that its Phase 2 AMPLIFY-7P study of ELI-002 7P did not meet the primary disease-free survival endpoint in the intent-to-treat population for adjuvant pancreatic cancer. However, post-hoc analyses showed promising results in the R0 resected patient subgroup (84% of enrolled patients) with a hazard ratio of 0.65 (p=0.048). Strong correlations between mutant KRAS-specific T cell responses and improved outcomes supported the drug's biological activity. The company plans to refine its Phase 3 strategy focusing on R0 resected patients with extended dosing, pending financing.

The Schall Law Firm is seeking investors who purchased Helen of Troy Limited securities between April 24, 2024 and October 8, 2025 to join a class action lawsuit. The company allegedly made false and misleading statements about its Project Pegasus restructuring program, overstating its success and cost savings while downplaying implementation issues. Investors who suffered losses are encouraged to contact the firm before August 3, 2026.

Rosen Law Firm has filed a class action lawsuit against Via Transportation, Inc. (NYSE: VIA) on behalf of IPO investors, alleging that the company's offering documents were false and misleading. The complaint claims Via omitted material facts about declining Platform Annual Run-Rate Revenue and inability to grow in Germany. Via's stock has declined approximately 70% from its IPO price to $14.52. The deadline to serve as lead plaintiff is August 10, 2026.

Rosen Law Firm is encouraging investors who purchased Zoetis Inc. securities between January 14, 2025 and May 6, 2026 to join a class action lawsuit. The lawsuit alleges that Zoetis made false statements about market share and sales growth while failing to disclose weakening adoption of key products like Librela due to FDA safety warnings, market share losses in Simparica Trio and dermatology products, and declining veterinarian adoption. The lead plaintiff deadline is July 27, 2026.

Rosen Law Firm is urging investors who purchased Veritone, Inc. securities between October 14, 2025 and April 14, 2026 to join a class action lawsuit before the July 20, 2026 lead plaintiff deadline. The lawsuit alleges that Veritone made false statements about its financial performance, inaccurately recorded revenue and costs, overstated assets, and maintained deficient internal controls, leading to required financial statement restatements.

Rosen Law Firm is notifying investors in Phreesia, Inc., Babcock & Wilcox Enterprises, Inc., and TruBridge, Inc. of ongoing securities class action lawsuits. Phreesia investors have until July 13, 2026 to serve as lead plaintiff. The lawsuit alleges Phreesia made false statements about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.

A securities class action lawsuit has been filed against Babcock & Wilcox Enterprises, Inc. for allegedly making false and misleading statements regarding a Power Generation contract with Applied Digital. The lawsuit claims that B&W's largest shareholder BRC Group Holdings stood on both sides of the contract and that Applied Digital did not actually need the products/services, raising questions about revenue recognition and overstating business prospects. Investors who purchased B&W securities between November 5, 2025 and March 11, 2026 may be eligible for compensation.

FREELANDER 8, a premium new energy vehicle co-created by Jaguar Land Rover and Chery, made its first public appearance at the Abu Dhabi Investment Forum in Shanghai on June 11, 2026. The British-Chinese collaboration aims to launch in the Middle East as its first strategic market, with plans to enter 90 countries and establish 1,100 touchpoints within five years.

FREELANDER, a premium new energy vehicle brand co-created by Jaguar Land Rover and Chery, unveiled the FREELANDER 8 at the Abu Dhabi Investment Forum in Shanghai. The brand plans to launch in the Middle East as its first international market, with ambitions to enter 90 countries and establish 1,100 touchpoints globally within five years.

Hamanasi Adventure & Dive Resort in Belize has been recognized as the #1 hotel in Central America and #15 best hotel globally in the 2026 TripAdvisor Travelers' Choice Best of the Best Awards. The luxury boutique resort, which employs over 180 Belizean staff, was recognized for exceptional service and guest experiences. The award is given to fewer than 1% of TripAdvisor's 8 million listings.

Rosen Law Firm is urging investors who purchased Graphic Packaging Holding Company (GPK) securities between February 4, 2025 and February 2, 2026 to join a class action lawsuit. The lawsuit alleges that the company made false statements regarding inventory management issues, reduced demand, increased costs, and overstated its business model strength. Investors must act by the July 6, 2026 lead plaintiff deadline.

Rosen Law Firm has filed a class action lawsuit against Helen of Troy Limited on behalf of investors who purchased common stock between April 24, 2024 and October 8, 2025. The lawsuit alleges misrepresentations regarding Project Pegasus, a restructuring program, where the company assured investors of progress despite acknowledged implementation issues with its Tennessee distribution center. The lead plaintiff deadline is August 3, 2026.

Rosen Law Firm has filed class action lawsuits against Verra Mobility Corporation, Erasca, Inc., and FS KKR Capital Corp. on behalf of investors who suffered losses. The Verra Mobility lawsuit alleges the company made false statements regarding its relationship with Avis Budget Group and concealed material adverse facts. Investors have until August 4, 2026 to move the court to serve as lead plaintiff.

The Schall Law Firm is seeking investors who purchased Helen of Troy Limited (HELE) securities between April 24, 2024 and October 8, 2025 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about its Project Pegasus restructuring program, overstating its success and cost-saving benefits while downplaying implementation issues.

Rosen Law Firm has filed a class action lawsuit against Via Transportation, Inc. (NYSE: VIA) on behalf of IPO investors, alleging that offering documents were false and misleading. The complaint claims Via omitted material facts about declining Platform Annual Run-Rate Revenue and inability to grow in Germany. Via's stock has declined approximately 70% from its IPO price to $14.52, and investors are encouraged to join the class action before the August 10, 2026 deadline to serve as lead plaintiff.

Rosen Law Firm has filed a class action lawsuit against BitGo Holdings, Inc. on behalf of investors who purchased securities during the company's January 2026 IPO and through May 2026. The lawsuit alleges that BitGo's offering documents contained materially false and misleading statements, specifically understating risks related to declining digital asset prices and their impact on the company's financial performance. Investors must move the court by August 7, 2026 to serve as lead plaintiff.

Rosen Law Firm is investigating potential securities claims against Elauwit Connection, Inc. (NASDAQ: ELWT) for allegedly issuing materially misleading business information. The company filed an 8-K on February 27, 2026, announcing non-reliance on previously issued interim financial statements due to errors in network construction project revenue recognition during the first nine months of 2025. Following this disclosure, ELWT's stock price fell $0.52 per share (6.8%) to $7.12 on March 2, 2026. The firm is preparing a class action lawsuit to recover investor losses.

Rosen Law Firm has filed a class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of investors who purchased common stock between April 16, 2025 and May 4, 2026. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's impact on the company's financials and operational efficiencies, while knowingly concealing significant viability problems that negatively affected the business. Investors must move the court by August 3, 2026 to serve as lead plaintiff.

Rosen Law Firm has filed class action lawsuits on behalf of investors in GRAIL, Inc. (NASDAQ: GRAL) who purchased stock between May 13, 2025 and February 19, 2026. The lawsuit alleges that GRAIL provided misleading statements regarding its NHS-Galleri trial results, concealing material adverse facts about the trial's ability to demonstrate cancer stage reduction. Investors who purchased during the class period may be eligible for compensation. The deadline to serve as lead plaintiff is August 4, 2026.

Rosen Law Firm is encouraging investors who purchased securities of Veritone, Inc. (NASDAQ: VERI) between October 14, 2025 and April 14, 2026 to join a class action lawsuit. The lawsuit alleges that Veritone made false statements regarding its financial reporting, inaccurately recorded revenue and costs, overstated assets, and maintained deficient internal controls, leading to required financial restatements. The firm is also investigating potential securities claims for GRAIL, Inc. and Barclays PLC shareholders.